Results 11 to 20 of about 16,213 (203)

Asystolic cardiac arrest following liposomal amphotericin B infusion: anaphylaxis or compliment activation-related pseudoallergy? [PDF]

open access: yesAllergy, Asthma & Clinical Immunology, 2021
Allergic reaction to liposomal amphotericin B is rare. We report a case of cardiac arrest in a 64-year-old woman following liposomal amphotericin B infusion, requiring resuscitation.
George P. Drewett   +4 more
doaj   +2 more sources

Liposomal amphotericin B and leishmaniasis: Dose and response

open access: yesJournal of Global Infectious Diseases, 2010
Liposomal amphotericin B has been used with increasing frequency to treat visceral leishmaniasis (VL). It is the treatment of choice for immunocompetent patients in the Mediterranean region and the preferred drug for HIV/VL co-infection.
Shyam Sundar, Jaya Chakravarty
doaj   +3 more sources

Methods for particle size reduction of liposomal amphotericin B

open access: yesVietnam Journal of Science, Technology and Engineering, 2018
Liposomal amphotericin B were prepared by thin film hydration technique. Particle size was reduced by ultrasonic device and high pressure homogeneous device.
Tuan Quang Nguyen   +3 more
doaj   +2 more sources

Successful haploidentical stem cell transplantation with prophylactic administration of liposomal amphotericin B after invasive pulmonary zygomycosis

open access: yesMedical Mycology Case Reports, 2017
A 54-year-old woman with acute myeloid leukemia (AML) achieved complete remission by induction chemotherapy, but developed zygomycosis after consolidation therapy.
Testuro Ochi   +8 more
doaj   +2 more sources

Lipsosomal amphotericin B: a review of its properties, function, and use for treatment of cutaneous leishmaniasis

open access: yesResearch and Reports in Tropical Medicine, 2019
Mohammad Reza Shirzadi1,21Center for Communicable Diseases Control, Ministry of Health and Medical Education, Tehran, Iran; 2Center for Research of Endemic Parasites of Iran (CREPI), Tehran University of Medical Science, Tehran, IranAbstract: The genus ...
Shirzadi MR
doaj   +1 more source

Reversible Ototoxicity: A Rare Adverse Reaction of Liposomal Amphotericin-B Used for the Treatment of Antimony-Resistant Visceral Leishmaniasis in an Elderly Male

open access: yesClinical Medicine Insights: Case Reports, 2014
Amphotericin-B, a broad spectrum antifungal agent, has been known to cause adverse effects such as nephrotoxicity and infusion-related side effects such as fever, chills, rigor, and arthralgias. However, ototoxicity as an adverse effect of Amphotericin-B
PC Das   +3 more
doaj   +2 more sources

Recurrent Candida albicans Ventriculitis Treated with Intraventricular Liposomal Amphotericin B

open access: yesCase Reports in Infectious Diseases, 2015
Central nervous system (CNS) infection with Candida is rare but significant because of its high morbidity and mortality. When present, it is commonly seen among immunocompromised and hospitalized patients.
Demet Toprak   +5 more
doaj   +3 more sources

Case report: Reversible encephalopathy associated with liposomal amphotericin B in a patient with cryptococcal meningitis

open access: yesFrontiers in Neurology, 2022
Liposomal amphotericin B (L-AMB) is an anti-fungus medicine that has fewer side effects than traditional amphotericin B (AMB). Neurotoxicity of L-AMB has rarely been observed, and only one case of leukoencephalopathy during intravenous L-AMB has been ...
Si Luo   +4 more
doaj   +1 more source

Disseminated Histoplasmosis in HIV-Infected Patients: A Description of 34 Years of Clinical and Therapeutic Practice

open access: yesJournal of Fungi, 2020
Disseminated histoplasmosis is the main AIDS-defining infection of French Guiana. We aim to describe our therapeutic experience for 349 patients with disseminated histoplasmosis between 1 January 1981 and 10 January 2014 in French Guiana.
Mathieu Nacher   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy